Skip to content

NMN for Mitochondrial Myopathy: What the Evidence Actually Shows

Category: musculoskeletal | ICD-10: G71.3 | Evidence tier: preliminary-human

What is Mitochondrial Myopathy?

Mitochondrial myopathies are inherited disorders of energy production in muscle, causing exercise intolerance, weakness and sometimes systemic features. Diagnosis relies on genetic and biopsy testing.

NMN relevance: the published evidence

Small NR (related precursor) studies in mitochondrial myopathy showed raised muscle NAD+ but inconsistent functional benefit. NMN itself has not been tested in these conditions in published trials. Care should be coordinated through a metabolic specialist.

Questions to ask before supplementing

No NMN dose validated; NR studies used 1000 mg/day.

Contraindications and red flags

Genetic disorders need specialist management; supplements should not replace evaluation.

Bottom line for Malaysian patients

NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have mitochondrial myopathy, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.

Related conditions

Cited references